NetraMark Holdings Inc. (TSX:AIAI)
Canada
· Delayed Price · Currency is CAD 0.920
-0.020 (-2.13%)
At close: Mar 6, 2026
NetraMark Holdings Company Description
NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide.
It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations.
The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.
NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
NetraMark Holdings Inc.
| Country | Canada |
| Founded | 2016 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | George Achilleos |
Contact Details
Address: 1655 Dupont Street Toronto, ON M6P 3T1 Canada | |
| Phone | 403 681 2549 |
| Website | netramark.com |
Stock Details
| Ticker Symbol | AIAI |
| Exchange | Toronto Stock Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| George Achilleos | President, Chief Executive Officer and Director |
| Dr. Joseph Geraci Ph.D. | Founder, Chief Scientific and Technical Officer and Director |
| Swapan Kakumanu ACA, ACWA, CGA | Chief Financial Officer and Corporate Secretary |
| Josh Spiegel | President of NetraMark Corp |
| Jaime Hackett | Vice President of Marketing |
| Dr. Luca Pani M.D. | Chief Innovation and Regulatory Officer and Chief Medical Advisor |
| Dr. Kaveh Kavoosi | Head of Progressive Medicine |
| Dr. Larry Alphs | Chief Medical Officer and Member of Advisory Board |
| Dr. Angelico Carta M.D. | Chief Strategy Officer |
| Dr. Jan Sedway Ph.D. | Senior Vice President of Clinical Science |